| GAK | NAK | Other | 4y8d | B | B | 2-methoxy-4-[3-(morpholin-4-yl)[1,2]thiazolo[4,3-b]pyridin-6-yl]aniline | Human | 342 | |
| GAK | NAK | Other | 4c57 | B | B | (2z,3e)-2,3'-biindole-2',3(1h,1'h)-dione 3-{o-[(3r)-3,4-dihydroxybutyl]oxime} | Human | 348 | |
| GAK | NAK | Other | 4c57 | A | B | (2z,3e)-2,3'-biindole-2',3(1h,1'h)-dione 3-{o-[(3r)-3,4-dihydroxybutyl]oxime} | Human | 340 | |
| GAK | NAK | Other | 4c57 | B | A | (2z,3e)-2,3'-biindole-2',3(1h,1'h)-dione 3-{o-[(3r)-3,4-dihydroxybutyl]oxime} | Human | 334 | |
| GAK | NAK | Other | 4c59 | A | B | (2z,3e)-2,3'-biindole-2',3(1h,1'h)-dione 3-{o-[(3r)-3,4-dihydroxybutyl]oxime} | Human | 346 | |
| GAK | NAK | Other | 5y80 | A | A | gefitinib | Human | 10329 | |
| GAK | NAK | Other | 4y8d | A | A | 2-methoxy-4-[3-(morpholin-4-yl)[1,2]thiazolo[4,3-b]pyridin-6-yl]aniline | Human | 344 | |
| GAK | NAK | Other | 4c59 | A | A | (2z,3e)-2,3'-biindole-2',3(1h,1'h)-dione 3-{o-[(3r)-3,4-dihydroxybutyl]oxime} | Human | 337 | |
| GAK | NAK | Other | 5y7z | A | | gefitinib | Human | 10332 | |
| GAK | NAK | Other | 4c57 | A | A | (2z,3e)-2,3'-biindole-2',3(1h,1'h)-dione 3-{o-[(3r)-3,4-dihydroxybutyl]oxime} | Human | 341 | |
| GAK | NAK | Other | 4o38 | B | A | - | Human | 338 | |
| GAK | NAK | Other | 5y7z | B | | gefitinib | Human | 10331 | |
| GAK | NAK | Other | 4o38 | A | B | - | Human | 335 | |
| GAK | NAK | Other | 4c58 | A | B | 9-hydroxy-4-phenylpyrrolo[3,4-c]carbazole-1,3(2h,6h)-dione | Human | 333 | |
| GAK | NAK | Other | 4y8d | B | A | 2-methoxy-4-[3-(morpholin-4-yl)[1,2]thiazolo[4,3-b]pyridin-6-yl]aniline | Human | 347 | |
| GAK | NAK | Other | 4o38 | A | A | - | Human | 345 | |
| GAK | NAK | Other | 5y80 | A | B | gefitinib | Human | 10330 | |
| GAK | NAK | Other | 4c58 | A | A | 9-hydroxy-4-phenylpyrrolo[3,4-c]carbazole-1,3(2h,6h)-dione | Human | 336 | |
| GAK | NAK | Other | 4o38 | B | B | - | Human | 343 | |
| GAK | NAK | Other | 4y8d | A | B | 2-methoxy-4-[3-(morpholin-4-yl)[1,2]thiazolo[4,3-b]pyridin-6-yl]aniline | Human | 339 | |
